Select Page

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

by | Apr 10, 2024 | Stocks


GLP-1 medications will likely expand beyond their current uses for diabetes or weight loss, according to money managers at Tema

Share it on social networks